EVIDENCE LIBRARY
Mouse Sleep Study Found Quercetin and Ascorbate Modified Diazepam-Related Effects in a Barbiturate Model
An experiment examined how quercetin and ascorbic acid changed drug-induced sleep in mice. Its behavioral and docking results did not establish a treatment for human benzodiazepine toxicity.
An experiment examined how quercetin and ascorbic acid changed drug-induced sleep in mice. Its behavioral and docking results did not establish a treatment for human benzodiazepine toxicity.
The tested combinations
The investigators used phenobarbital-induced sleep with quercetin, ascorbic acid, diazepam, and flumazenil in defined experimental combinations. They measured sleep onset and duration.
The supplements modified these endpoints, including partial reversal of diazepam-related effects, and some combinations showed a stimulatory-like pattern. Molecular docking supplied additional receptor-interaction hypotheses.
Keep the interaction model intact
The endpoint depended on a barbiturate challenge and injected study compounds. Changes could involve several pharmacodynamic or disposition processes, and docking does not establish functional receptor action.
The authors regarded the mechanism as unresolved. The paper cannot justify using dietary supplements as an antidote, predict effects of ordinary oral intake, or establish safety with prescribed sedatives. An accurate summary retains the mouse model, exact co-treatment context, and distinct onset and duration findings rather than presenting a preclinical interaction as demonstrated clinical reversal.
Source paper
Original analysis of the supplied journal article, identified as PMC8398796.